These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1311989)

  • 1. Aflatoxins as risk factors for hepatocellular carcinoma in humans.
    Wogan GN
    Cancer Res; 1992 Apr; 52(7 Suppl):2114s-2118s. PubMed ID: 1311989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of chemicals on liver cancer risk.
    Wogan GN
    Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary risk factors for primary hepatocellular carcinoma.
    Wogan GN
    Cancer Detect Prev; 1989; 14(2):209-13. PubMed ID: 2559796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
    Harris CC; Sun TT
    Cancer Surv; 1986; 5(4):765-80. PubMed ID: 3040243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aflatoxin, viral hepatitis and primary liver cancer.
    Stora C; Dvorackova I
    J Med; 1987; 18(1):23-41. PubMed ID: 3036991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
    Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
    Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
    Autrup H; Seremet T; Wakhisi J; Wasunna A
    Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
    Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical carcinogenesis: mycotoxins and other chemicals to which humans are exposed.
    Newberne PM
    Semin Liver Dis; 1984 May; 4(2):122-35. PubMed ID: 6087458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.
    Ayoola EA
    IARC Sci Publ; 1984; (63):167-79. PubMed ID: 6100268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA; London WT
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
    McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH
    Cancer Res; 2003 Aug; 63(15):4594-601. PubMed ID: 12907637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma--a model of human cancer: clinico-pathological features, etiology and pathogenesis.
    Nayak NC
    Indian J Pathol Microbiol; 2003 Jan; 46(1):1-16. PubMed ID: 15027710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
    Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma: risk factors other than HBV.
    Villa E; Melegari M; Scaglioni PP; Trande P; Cesaro P; Manenti F
    Ital J Gastroenterol; 1991; 23(7):457-60. PubMed ID: 1660333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBsAg, aflatoxins and primary hepatocellular carcinoma.
    Olubuyide IO; Maxwell SM; Hood H; Neal GE; Hendrickse RG
    Afr J Med Med Sci; 1993 Sep; 22(3):89-91. PubMed ID: 7839921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
    Wild CP; Montesano R
    Cancer Lett; 2009 Dec; 286(1):22-8. PubMed ID: 19345001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.